Ipilimumab vs Niacinamide
Ipilimumab vs Niacinamide: Overview
This comparison examines the pharmacological differences between Ipilimumab and Niacinamide.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days.
Chemical Properties
Type: Ipilimumab β Antibody; Niacinamide β Small molecule.